Resultados de procura - Richard M. Sherry

Limitar resultados
  1. 1
    Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma

    Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma por Liqiang Xi, Trinh H. Pham, Eden C. Payabyab, Richard M. Sherry, Steven A. Rosenberg, Mark Raffeld

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy

    Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy por Jenny J. Hong, Steven A. Rosenberg, Mark E. Dudley, James Chih‐Hsin Yang, Donald E. White, John A. Butman, Richard M. Sherry

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Determination of the Elimination Half-Life of Fibroblast Growth Factor-23

    Determination of the Elimination Half-Life of Fibroblast Growth Factor-23 por Azarmindokht Khosravi, Carolee M. Cutler, Marilyn H Kelly, Richard Chang, Richard E. Royal, Richard M. Sherry, Felasfa M. Wodajo, Neal S. Fedarko, Michael T. Collins

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

    Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy por Kathryn M. Cappell, Richard M. Sherry, James C. Yang, Stephanie L. Goff, Danielle Vanasse, Lori McIntyre, Steven A. Rosenberg, James N. Kochenderfer

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma

    CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma por Peter A. Prieto, James Chih‐Hsin Yang, Richard M. Sherry, Marybeth S. Hughes, Udai S. Kammula, Donald E. White, Catherine Lévy, Steven A. Rosenberg, Giao Q. Phan

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

    A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer por James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Seth M. Steinberg, Helen X. Chen, Steven A. Rosenberg

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

    Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma por Richard E. Royal, Catherine Lévy, Keli Turner, Aarti Mathur, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Israel Lowy, Steven A. Rosenberg

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma

    High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma por Jacob A. Klapper, Stephanie G. Downey, Franz O. Smith, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Richard E. Royal, Seth M. Steinberg, Steven A. Rosenberg

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL

    Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL por Stephanie L. Goff, Franz O. Smith, Jacob A. Klapper, Richard M. Sherry, John R. Wunderlich, Seth M. Steinberg, Donald White, Steven A. Rosenberg, Mark E. Dudley, James C. Yang

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy por James N. Kochenderfer, Robert Somerville, Tangying Lu, James C. Yang, Richard M. Sherry, Steven A. Feldman, Lori McIntyre, Adrian Bot, John M. Rossi, Norris Lam, Steven A. Rosenberg

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases

    Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases por Gautam U. Mehta, Parisa Malekzadeh, Thomas E. Shelton, Donald E. White, John A. Butman, James Chih‐Hsin Yang, Udai S. Kammula, Stephanie L. Goff, Steven A. Rosenberg, Richard M. Sherry

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

    Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with respo... por Barbara A. Pockaj, Richard M. Sherry, John P. Wei, John R. Yannelli, Charles S. Carter, Susan F. Leitman, Jorge A. Carasquillo, Seth M. Steinberg, Steven A. Rosenberg, James Chih‐Hsin Yang

    Publicado 1994
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer

    Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer por Joseph Blansfield, Kimberly E Beck, Khoi Tran, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Suzanne L. Topalian, Leah Haworth, Catherine Lévy, Steven A. Rosenberg, Richard M. Sherry

    Publicado 2005
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

    Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans por Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study

    T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study por Stacey L. Doran, Sanja Stevanović, Sabina Adhikary, Jared J. Gartner, Li Jia, Mei Li M. Kwong, William C. Faquin, Stephen M. Hewitt, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Christian S. Hinrichs

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

    Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis por James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Richard M. Sherry, Suzanne L. Topalian, Kimberly B. Suri, Catherine Lévy, Tamika Allen, Sharon Mavroukakis, Israel Lowy, Donald E. White, Steven A. Rosenberg

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma

    Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma por Ajay V. Maker, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Marybeth S. Hughes, Michael Yellin, Leah Haworth, Catherine Lévy, Tamika Allen, Sharon Mavroukakis, Peter Attia, Steven A. Rosenberg

    Publicado 2006
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen

    Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen por Steven A. Rosenberg, James C. Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Nicholas P. Restifo, Leah Haworth, Claudia A. Seipp, Linda J. Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White

    Publicado 2003
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines

    Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines por Franz O. Smith, Stephanie G. Downey, Jacob A. Klapper, James C. Yang, Richard M. Sherry, Richard E. Royal, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Catherine Lévy, Donald E. White, Seth M. Steinberg, Steven A. Rosenberg

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

    Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study por Ajay V. Maker, Giao Q. Phan, Peter Attia, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Leah Haworth, Catherine Lévy, David E. Kleiner, Sharon Mavroukakis, Michael Yellin, Steven A. Rosenberg

    Publicado 2005
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: